Two-Stage Reimplantation of a Prosthetic Hip Infection: Systematic Review of Long-Term Reinfection and Pathogen Outcomes

Published:February 22, 2021DOI:https://doi.org/10.1016/j.arth.2021.02.046

      Abstract

      Background

      Although two-stage exchange for chronic periprosthetic hip infections remains an effective option for infection eradication, long-term outcome reporting remains scarce. Compiling outcomes data for this standard of care is necessary to characterize long-term reinfection risk and identify bacteria associated with reinfection. The purpose of our study was to perform a systematic review to determine the long-term risk of reinfection after two-stage reimplantation. The second purpose was to identify the proportion of reinfections caused by the same or different organism(s) relative to the index infection.

      Methods

      We performed a systematic review of two-stage reimplantation randomized control trials, cohort studies, and case series for the treatment of periprosthetic joint infections, yielding 320 unique citations for abstract review, of which 138 were reviewed in full. We collected reinfection data including the timing of reinfection after successful reimplantation and the bacteria identified at reinfection. Meeting inclusion criteria were 28 studies with 2047 patients and 2055 hips that completed both reimplantation stages with just seven studies having greater than 24 month follow-up.

      Results

      Studies with longer average follow-up reported significantly higher all-time reinfection rates (P = .042). Among studies with at least 5 years of follow-up, the risk of reinfection was 10.25% (8.21-12.47). Among studies with minimum follow-up of at least 24 months, the 24-month rate of reinfection was 4.58% (2.17-7.66), which increased to 7.34% (4.44-10.82) by final follow-up. Only 12 studies reported index and recurrent pathogen data. In those studies, 3.00% (1.19-5.38) of all hips which completed both reimplantation stages were reinfected by a new pathogen, and 1.70% (0.52-3.35) of patients became reinfected by recurrent pathogens.

      Conclusion

      While the majority of two stage reimplantation literature follows patients for two years, there is significant risk of reinfection into the long term. Further studies with detailed outcomes and long-term follow-up are needed to identify factors associated with late infections.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Arthroplasty
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Akgun D.
        • Muller M.
        • Perka C.
        • Winkler T.
        High cure rate of periprosthetic hip joint infection with multidisciplinary team approach using standardized two-stage exchange.
        J Orthop Surg Res. 2019; 14: 78
        • Beswick A.D.
        • Elvers K.T.
        • Smith A.J.
        • Gooberman-Hill R.
        • Lovering A.
        • Blom A.W.
        What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patients.
        BMC Med. 2012; 10: 18
        • Chen W.
        • Fu T.
        • Wang J.
        Two-stage reimplantation of infected hip arthroplasties.
        Chang Gung Med J. 2009; 32: 188-197
        • Fink B.
        • Grossmann A.
        • Fuerst M.
        • Schäfer P.
        • Frommelt L.
        Two-stage cementless revision of infected hip endoprostheses.
        Clin Orthop Relat Res. 2009; 467: 1848-1858
        • Koo K.H.
        • Yang J.W.
        • Cho S.H.
        • Song H.R.
        • Park H.B.
        • Ha Y.C.
        • et al.
        Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty.
        J Arthroplasty. 2001; 16: 882-892
        • Kraay M.J.
        • Goldberg V.M.
        • Fitzgerald S.J.
        • Salata M.J.
        Cementless two-staged total hip arthroplasty for deep periprosthetic infection.
        Clin Orthop Relat Res. 2005; 441: 243-249
        • Lange J.
        Chronic infections in hip arthroplasties: comparing risk of reinfection following one-stage and two-stage revision: a systematic review and meta-analysis.
        Clin Epidemiol. 2012; 4: 57-73
        • Leung F.
        • Richards C.J.
        • Garbuz D.S.
        • Masri B.A.
        • Duncan C.P.
        Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection?.
        Clin Orthop Relat Res. 2011; 469: 1009-1015
        • Lieberman J.R.
        • Callaway G.H.
        • Salvati E.A.
        • Pellicci P.M.
        • Brause B.D.
        Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol.
        Clin Orthop Relat Res. 1994; 301: 205-212
        • Masters J.P.M.
        A systematic review of the evidence for single stage and two stage revision of infected knee replacement.
        BMC Musculoskelet Disord. 2007; 14: 222
        • McKenna P.B.
        • O'Shea K.
        • Masterson E.L.
        Two-stage revision of infected hip arthroplasty using a shortened post-operative course of antibiotics.
        Arch Orthop Trauma Surg. 2009; 129: 489-494
        • Sanchez-Sotelo J.
        • Berry D.J.
        • Hanssen A.D.
        • Cabanela M.E.
        Midterm to long-term followup of staged reimplantation for infected hip arthroplasty.
        Clin Orthop Relat Res. 2009; 467: 219-224
        • Stockley I.
        • Mockford B.J.
        • Hoad-Reddick A.
        • Norman P.
        The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement.
        J Bone Joint Surg Br. 2008; 90: 145-148
        • Tsukayama D.T.
        • Estrada R.
        • Gustilo R.B.
        Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections.
        J Bone Joint Surg Am. 1996; 78: 512-523
        • van Diemen M.P.
        • Colen S.
        • Dalemans A.A.
        • Stuyck J.
        • Mulier M.
        Two-stage revision of an infected total hip arthroplasty: a follow-up of 136 patients.
        Hip Int. 2013; 23: 445-450
        • Fillingham Y.A.
        • Della Valle C.J.
        • Suleiman L.I.
        • Springer B.D.
        • Gehrke T.
        • Bini S.A.
        • et al.
        Definition of successful infection management and guidelines for reporting of outcomes after surgical treatment of periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society (MSIS).
        JBJS. 2019; 101: e69
        • Harris J.D.
        • Quatman C.E.
        • Manring M.M.
        • Siston R.A.
        • Flanigan D.C.
        How to write a systematic review.
        Am J Sports Med. 2014; 42: 2761-2768
        • Petis S.M.
        • Abdel M.P.
        • Perry K.I.
        • Mabry T.M.
        • Hanssen A.D.
        • Berry D.J.
        Long-term results of a 2-stage exchange protocol for periprosthetic joint infection following total hip arthroplasty in 164 hips.
        J Bone Joint Surg Am. 2019; 101: 74-84
        • Gallo J.
        • Smizansky M.
        • Radova L.
        • Potomkova J.
        Comparison of therapeutic strategies for hip and knee prosthetic joint infection.
        Acta Chir Orthop Traumatol Cech. 2009; 76: 302-309
        • Sanchez-Sotelo J.
        • Berry D.J.
        • Hanssen A.D.
        • Cabanela M.E.
        Midterm to long-term followup of staged reimplantation for infected hip arthroplasty.
        Clin Orthop Relat Res. 2009; 467: 219-224
        • Zmistowski B.
        • Tetreault M.W.
        • Alijanipour P.
        • Chen A.F.
        • Della Valle C.J.
        • Parvizi J.
        Recurrent periprosthetic joint infection: persistent or new infection?.
        J Arthroplasty. 2013; 28: 1486-1489
        • Kilgus D.J.
        • Howe D.J.
        • Strang A.
        Results of periprosthetic hip and knee infections caused by resistant bacteria.
        Clin Orthop Relat Res. 2002; : 116-124
        • Volin S.J.
        • Hinrichs S.H.
        • Garvin K.L.
        Two-stage reimplantation of total joint infections: a comparison of resistant and non-resistant organisms.
        Clin Orthop Relat Res. 2004; : 94-100
        • Garvin K.L.
        • Miller R.E.
        • Gilbert T.M.
        • White A.M.
        • Lyden E.R.
        Late reinfection may recur more than 5 years after reimplantation of THA and TKA: analysis of pathogen factors.
        Clin Orthop Relat Res. 2018; 476: 345-352